Lonza

Lonza Group AG is a Swiss multinational manufacturing company based in Basel, specializing in contract development and manufacturing services for the pharmaceutical, biotechnology, and nutrition sectors. Founded in 1897, Lonza has evolved from its origins in hydroelectric power to become a leader in biopharmaceutical manufacturing, operating over thirty development and manufacturing sites worldwide. As a pure-play contract development and manufacturing organization (CDMO), Lonza offers a wide range of services, including biologics manufacturing, small molecules production, bioconjugates, and cell and gene therapies. The company also provides drug product services and detection systems for the bioscience sector. Lonza has established significant partnerships with major pharmaceutical companies, including a notable collaboration with Moderna for the production of its COVID-19 vaccine. With a strong market position, Lonza plays a crucial role in the growth of outsourced drug manufacturing and the development of innovative therapies.

Partnerships

 

  

  

 

  

  

 

  

  

Clients